- Home
- CRVO vs SATL Comparison
CRVO vs SATL Comparison
Compare CRVO & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- SATL
- Stock Information
- Founded
- CRVO 2001
- SATL 2010
- Country
- CRVO United States
- SATL United States
- Employees
- CRVO N/A
- SATL N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- CRVO Health Care
- SATL Technology
- Exchange
- CRVO Nasdaq
- SATL Nasdaq
- Market Cap
- CRVO 67.4M
- SATL 433.8M
- IPO Year
- CRVO N/A
- SATL N/A
- Fundamental
- Price
- CRVO $5.80
- SATL $3.58
- Analyst Decision
- CRVO Strong Buy
- SATL
- Analyst Count
- CRVO 8
- SATL 0
- Target Price
- CRVO $25.57
- SATL N/A
- AVG Volume (30 Days)
- CRVO 139.4K
- SATL 1.8M
- Earning Date
- CRVO 08-08-2025
- SATL 08-14-2025
- Dividend Yield
- CRVO N/A
- SATL N/A
- EPS Growth
- CRVO N/A
- SATL N/A
- EPS
- CRVO N/A
- SATL N/A
- Revenue
- CRVO $9,308,215.00
- SATL $12,929,000.00
- Revenue This Year
- CRVO N/A
- SATL N/A
- Revenue Next Year
- CRVO N/A
- SATL N/A
- P/E Ratio
- CRVO N/A
- SATL N/A
- Revenue Growth
- CRVO 15.14
- SATL 9.47
- 52 Week Low
- CRVO $1.80
- SATL $0.72
- 52 Week High
- CRVO $20.63
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- CRVO 32.36
- SATL 48.56
- Support Level
- CRVO $6.31
- SATL $3.43
- Resistance Level
- CRVO $7.20
- SATL $3.93
- Average True Range (ATR)
- CRVO 0.52
- SATL 0.21
- MACD
- CRVO -0.10
- SATL 0.02
- Stochastic Oscillator
- CRVO 9.20
- SATL 54.32
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.